Jacobs Levy Equity Management, Inc Sana Biotechnology, Inc. Transaction History

Jacobs Levy Equity Management, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	BUY	$3.77 - $6.23 $395,914 - $654,255	105,017 Added 125.27%	188,848 $730,000
Q2 2023 Aug 14, 2023	SELL	$3.22 - $7.53 $647,999 - $1.52 Million	-201,242 Reduced 70.59%	83,831 $499,000
Q1 2023 May 15, 2023	BUY	$3.11 - $4.92 $886,577 - $1.4 Million	285,073 New	285,073 $932,000

174

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $314M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.